• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number UNKENTERPRISE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thromboembolism (2654)
Event Date 10/01/2015
Event Type  Injury  
Manufacturer Narrative
Manufacturer's ref.No: (b)(4).This complaint is from a literature source and the following citation was reviewed: zang y, wang c, zhang y, ding x, wang y, wang x, wang z.Long-term follow-up study of 35 cases after endovascular treatment for vertebrobasilar dissecting aneurysms.Clin neurol neurosurg.2015 oct;137:121-31.Doi: 10.1016/j.Clineuro.2015.07.004.Epub 2015 jul 7.Pmid: 26196477.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
This complaint is from a literature source and the following citation was reviewed: zang y, wang c, zhang y, ding x, wang y, wang x, wang z.Long-term follow-up study of 35 cases after endovascular treatment for vertebrobasilar dissecting aneurysms.Clin neurol neurosurg.2015 oct;137:121-31.Doi: 10.1016/j.Clineuro.2015.07.004.Epub 2015 jul 7.Pmid: 26196477.Objective and methods: authors report experiences using endovascular treatment for vbda patients to assess the efficacy and safety of several vbda treatment strategies.Assisted by intra-arterial digital subtraction angiography, 35 patients in our hospital were treated using various vbda treatment strategies, including stent-assisted coil embolization (20 patients), placement of single or multiple overlapping stents (5 patients) or coil embolization combined with proximal coil trapping of the dissected segment of the parent artery (ce + pt; 10 patients).The articles notes deaths and complications as not related to device (s) but due to the complexity of the presenting conditions of ruptured vbda with subarachnoid hemorrhage (sah).Lot, model and catalog number are not available, but the suspected cerenovus device possibly associated with reported adverse events: enterprise stent.Other cerenovus devices that were also used in this study: a 6f or 7f envoy guiding catheter, prowler plus microcatheter non-cerenovus devices that were also used in this study: traxcess guidewire (microventioninc), neuroform stent (neuroform boston scientific).Coils were utilized but the article does not identify manufacturer of coils.Article also does not identify which manufacturer devices are associated with the adverse events.Adverse event(s) and provided interventions: patient no 18 (b)(6) female with presenting sah had intraoperative thrombi in the parent artery and treated with urokinase (failed) and tirofiban (successful) resulting in complete patency.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STENT - VASCULAR RECONSTRUCTION
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle nechatel CH240 0
SZ  CH2400
MDR Report Key12597974
MDR Text Key282492180
Report Number1226348-2021-00088
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
PMA/PMN Number
H60001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial
Report Date 09/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKENTERPRISE
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/12/2021
Initial Date FDA Received10/08/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
A 6F OR 7F ENVOY GUIDING CATHETER; NEUROFORM STENT (NEUROFORM BOSTON SCIENTIFIC); PROWLER PLUS MICROCATHETER; TRAXCESS GUIDEWIRE (MICROVENTIONINC)
Patient Outcome(s) Other;
Patient Age49 YR
-
-